Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapy

BACKGROUND: Nephropathy is an important feature of classical Fabry disease, which results in alpha-galactosidase A deficiency and cellular globotriaosylceramide accumulation. We report the safety and efficacy of antiproteinuric therapy with ACE inhibitors or angiotensin II receptor blockers (ARBs) i...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Med Genet
Hlavní autoři: Warnock, David G, Thomas, Christie P, Vujkovac, Bojan, Campbell, Ruth C, Charrow, Joel, Laney, Dawn A, Jackson, Leslie L, Wilcox, William R, Wanner, Christoph
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2015
Témata:
Phenotypes
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4717450/
https://ncbi.nlm.nih.gov/pubmed/26490103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jmedgenet-2015-103471
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky